Clinical trial
Utility of Urine Mass Spectrometry Analysis in Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension
NCT06938633 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility of Urine Mass Spectrometry Analysis in Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension
- Lead sponsor
- Changi General Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 7, 2024
- Completion date
- September 30, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertension, non-adherence, medication, uncontrolled hypertension